FI890678A - Analogiförfarande för framställning av terapeutiskt användbara 1,3-dioxanalkensyraderivat - Google Patents
Analogiförfarande för framställning av terapeutiskt användbara 1,3-dioxanalkensyraderivat Download PDFInfo
- Publication number
- FI890678A FI890678A FI890678A FI890678A FI890678A FI 890678 A FI890678 A FI 890678A FI 890678 A FI890678 A FI 890678A FI 890678 A FI890678 A FI 890678A FI 890678 A FI890678 A FI 890678A
- Authority
- FI
- Finland
- Prior art keywords
- dioxane
- preparation
- acid derivatives
- therapeutically useful
- analogous process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888803516A GB8803516D0 (en) | 1988-02-16 | 1988-02-16 | Heterocyclic compounds |
GB8803516 | 1988-02-16 | ||
GB888824666A GB8824666D0 (en) | 1988-10-21 | 1988-10-21 | Pyridine derivatives |
GB8824666 | 1988-10-21 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI890678A0 FI890678A0 (sv) | 1989-02-13 |
FI890678A true FI890678A (sv) | 1989-08-17 |
FI93216B FI93216B (sv) | 1994-11-30 |
FI93216C FI93216C (sv) | 1995-03-10 |
Family
ID=26293498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI890678A FI93216C (sv) | 1988-02-16 | 1989-02-13 | Analogiförfarande för framställning av terapeutiskt användbara 1,3-dioxanalkensyraderivat |
Country Status (24)
Country | Link |
---|---|
US (1) | US5166213A (sv) |
EP (1) | EP0329360B1 (sv) |
JP (1) | JP2812697B2 (sv) |
KR (1) | KR0145725B1 (sv) |
CN (1) | CN1040753C (sv) |
AR (1) | AR246965A1 (sv) |
AT (1) | ATE109478T1 (sv) |
AU (1) | AU626534B2 (sv) |
CA (1) | CA1335816C (sv) |
DE (1) | DE68917170T2 (sv) |
DK (1) | DK66989A (sv) |
ES (1) | ES2057104T3 (sv) |
FI (1) | FI93216C (sv) |
GB (1) | GB8901201D0 (sv) |
HU (1) | HU209700B (sv) |
IE (1) | IE63825B1 (sv) |
IL (1) | IL89214A (sv) |
MY (1) | MY103699A (sv) |
NO (1) | NO172491C (sv) |
NZ (1) | NZ227880A (sv) |
PH (1) | PH26227A (sv) |
PL (1) | PL158201B1 (sv) |
PT (1) | PT89703B (sv) |
ZW (1) | ZW1789A1 (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8709794D0 (en) * | 1987-04-24 | 1987-05-28 | Ici Plc | Heterocyclic acids |
IE81170B1 (en) * | 1988-10-21 | 2000-05-31 | Zeneca Ltd | Pyridine derivatives |
GB9021571D0 (en) * | 1990-10-04 | 1990-11-21 | Ici Plc | Heterocyclic acids |
EP2363127A1 (en) * | 2006-01-18 | 2011-09-07 | Evolva SA | PPAR Modulators |
JP5662682B2 (ja) * | 2007-01-18 | 2015-02-04 | エヴォルヴァ エスアー | Pparモジュレータとして有用な置換1,3−ジオキサン |
US20100273824A1 (en) | 2007-01-18 | 2010-10-28 | Evolva Sa | Substituted 1,3-dioxanes and their uses |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0062238B1 (de) * | 1981-03-30 | 1985-01-30 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | 1,3-Dioxolan-Derivate, Herstellung dieser Verbindungen, fungizide Mittel, die diese Verbindungen als Wirkstoffe enthalten sowie Verwendung solcher Verbindungen bzw. Mittel zur Bekämpfung von Fungi in der Landwirtschaft und im Gartenbau |
GB8310407D0 (en) * | 1982-05-12 | 1983-05-25 | Ici Plc | 1 3 - dioxan -5- ylalkenoic acids |
GB8330120D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Chemical process |
GB8330099D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Cycloalkane derivatives |
GB8330094D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Diphenyl compounds |
US4554011A (en) * | 1984-08-24 | 1985-11-19 | Chevron Research Company | Herbicidal 2S-(2β,4β,5β)-5-Arylmethoxy-4-substituted 2-alkyl-1,3-dioxane derivatives |
GB8511892D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Fluoralkane derivatives |
GB8511894D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Phenol derivatives |
HU198706B (en) * | 1985-05-10 | 1989-11-28 | Ici Plc | Process for producing 1,3-dioxan-ethers and pharmaceutical compositions containing them |
GB8511895D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Heterocyclic compounds |
GB8511890D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Benzene derivatives |
EP0201352B1 (en) * | 1985-05-10 | 1992-06-24 | Imperial Chemical Industries Plc | Alkene derivatives |
GB8511891D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Alkenoic acids |
GB8611174D0 (en) * | 1986-05-08 | 1986-06-18 | Ici Plc | Amide derivatives |
AU584763B2 (en) * | 1985-11-12 | 1989-06-01 | Imperial Chemical Industries Plc | N-(6-(4-0-hydrxyphenyl-1,3-dioxan-cis-5-yl)hexenoyl) suphonamide derivatives |
GB8531892D0 (en) * | 1985-12-30 | 1986-02-05 | Ici Plc | Carboxylic acids |
GB8626297D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Pharmaceutical compositions |
GB8626296D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Therapeutic agents |
GB8709794D0 (en) * | 1987-04-24 | 1987-05-28 | Ici Plc | Heterocyclic acids |
IE81170B1 (en) * | 1988-10-21 | 2000-05-31 | Zeneca Ltd | Pyridine derivatives |
-
1989
- 1989-01-19 GB GB898901201A patent/GB8901201D0/en active Pending
- 1989-02-07 IE IE39289A patent/IE63825B1/en not_active IP Right Cessation
- 1989-02-07 IL IL8921489A patent/IL89214A/en not_active IP Right Cessation
- 1989-02-07 NZ NZ227880A patent/NZ227880A/xx unknown
- 1989-02-08 CA CA000590484A patent/CA1335816C/en not_active Expired - Fee Related
- 1989-02-13 PT PT89703A patent/PT89703B/pt active IP Right Grant
- 1989-02-13 PH PH38187A patent/PH26227A/en unknown
- 1989-02-13 NO NO890607A patent/NO172491C/no unknown
- 1989-02-13 ES ES89301334T patent/ES2057104T3/es not_active Expired - Lifetime
- 1989-02-13 CN CN89100858A patent/CN1040753C/zh not_active Expired - Fee Related
- 1989-02-13 ZW ZW17/89A patent/ZW1789A1/xx unknown
- 1989-02-13 HU HU89632A patent/HU209700B/hu not_active IP Right Cessation
- 1989-02-13 AT AT89301334T patent/ATE109478T1/de not_active IP Right Cessation
- 1989-02-13 JP JP1031263A patent/JP2812697B2/ja not_active Expired - Lifetime
- 1989-02-13 DK DK066989A patent/DK66989A/da not_active Application Discontinuation
- 1989-02-13 KR KR1019890001661A patent/KR0145725B1/ko not_active IP Right Cessation
- 1989-02-13 DE DE68917170T patent/DE68917170T2/de not_active Expired - Fee Related
- 1989-02-13 AU AU29908/89A patent/AU626534B2/en not_active Ceased
- 1989-02-13 FI FI890678A patent/FI93216C/sv not_active IP Right Cessation
- 1989-02-13 EP EP89301334A patent/EP0329360B1/en not_active Expired - Lifetime
- 1989-02-13 PL PL1989277709A patent/PL158201B1/pl unknown
- 1989-02-14 US US07/310,235 patent/US5166213A/en not_active Expired - Fee Related
- 1989-02-14 AR AR89313211A patent/AR246965A1/es active
- 1989-02-16 MY MYPI89000189A patent/MY103699A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI890282A0 (sv) | Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat | |
FI96861C (sv) | Förfarande för framställning av terapeutiskt aktiva substituerade indolylpyrrolderivat | |
FI905941A0 (sv) | Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat | |
FI92934B (sv) | Analogiförfarande för framställning av terapeutiskt användbara 1-deoxinojirimycinderivat | |
NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
FI874459A0 (sv) | Förfarande för framställning av terapeutiskt användbara piperidinderivat | |
FI890245A0 (sv) | Förfarande för framställning av terapeutiskt användbara 1,4-disubstituerade piperidinylderivat | |
FI94752C (sv) | Förfarande för framställning av terapeutiskt användbara propenonoximetrar | |
FI895417A0 (sv) | Förfarande för framställning av nya terapeutiskt användbara 2'-halometylidennukleosider | |
FI896249A0 (sv) | Förfarande för framställning av terapeutiskt användbara 7-oxabicykloheptylsubstituerade heterocykliska amidprostaglandinderivat | |
FI891339A (sv) | Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat | |
NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
FI880467A0 (sv) | Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner | |
FI871087A0 (sv) | Förfarande för framställning av terapeutiskt användbara 1,2,3,4-tetrahydro-3-karbamoyl-2-tioxo/oxo-5-pyrimidinkarboxylsyraderivat | |
FI883672A (sv) | Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat | |
FI873350A (sv) | Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat | |
FI93106C (sv) | Förfarande för framställning av som läkemedel användbara 2-iminobenzotiazolinderivat | |
NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
FI893003A (sv) | Förfarande för framställning av terapeutiskt användbara neplanocinderivat | |
FI884660A0 (sv) | Förfarande för framställning av terapeutiskt aktiva 2,2-dimetylkromenderivat | |
FI895983A0 (sv) | Förfarande för framställning av som läkemedel användbara 2-benzotiazolinderivat | |
FI903077A0 (sv) | Förfarande för framställning av terapeutiskt aktiva R(-)-3-kinuklidinolderivat | |
FI900145A (sv) | Förfarande för framställning av farmaceutiskt användbara 1,1-dioxo-cefem-4-karbotiolsyraderivat | |
FI890678A0 (sv) | Analogiförfarande för framställning av terapeutiskt användbara 1,3-dioxanalkensyraderivat | |
FI884473A (sv) | Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed |
Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC |